skip to content

It’s Breast Cancer Awareness Month. Early interventions lead to better outcomes. Discover key facts and prevention strategies for breast cancer today.

News & Articles

Why I’m Excited to Join Color Health: Impact at Scale

Rebecca Miksad MD MMS MPH

I am thrilled to join Color Health as the Chief Medical Officer because I am passionate about leveraging data and technology to advance health equity in cancer outcomes. As a tech-forward company, Color’s patient-centric platform and expert clinical care is poised to reshape the cancer care continuum from screening and prevention to promoting healthy survivorship. My vision is freeing patients from the burden of cancer: impact at scale.

In this first installment of a three-part series, I will explore the broad impact of technology in revolutionizing cancer care. Over the coming weeks, we will delve into the general impact at scale, address health equity issues, and look towards the future of data and AI in oncology.

A Journey of Innovation and Impact

My career has been dedicated to advancing cancer care and breaking down barriers to access through data and technology. I bring to my healthtech leadership roles my commitment to high quality patient care as a physician and as a researcher committed to evidence-based medicine. Some might say I am a bit of a data nerd.

Before joining Color Health, I was fortunate to help build some of the earliest products and services at Flatiron Health and to pioneer the world of real-world evidence (RWE), including setting standards for regulatory use-cases. As an academic physician who moved from an NIH-funded decision scientist and clinical trial leader at Harvard to an early stage health technology company more than seven years ago, I quickly learned that fit-for-purpose technology and analytics was essential to accelerate progress for cancer at the population level. I bring this deep appreciation for the strengths (and limitations) of technology, AI and data, to the heart of Color’s work to expand access to evidence-based cancer screening and supportive clinical care to patients with cancer from diagnosis, through treatment and into survivorship. 

My work treating patients with cancer and high risk cancer genetics at Boston Medical Center deeply informs everything I do and is the source of my motivation. My patients and their families continue to amaze me with their resilience and insight: over and over again they tell me how the fragmented US healthcare system delayed the diagnosis of cancer, kept them up at night with financial and logistical worries, and disrupted their commitments to work, family and friends with symptoms and unexpected challenges. Many times, these are outside the control of any one patient and any one physician. I feel so lucky to help close these gaps to improve cancer outcomes and to foster healthy survivorship broadly: Impact at scale

Color Health’s Vision for Transformation

Color Health’s vision aims to transform cancer screening, treatment and survivorship to a health-full journey for everyone across diverse populations and geographies. The integrated technology, AI and compassionate clinical care platform is a catalyst for change.I am excited to collaborate with my colleagues at Color Health to push the boundaries of what’s possible in oncology.

I welcome you to join us on this exciting and transformative journey to reduce the burden of cancer for everyone. Stay tuned for the next posts in this series, where we will delve into the critical aspects of health equity and the future of data and AI in oncology.

Color

Using AI to Accelerate Cancer Diagnosis to Treatment Time for Your Workforce

Color

Bringing cancer expertise to a doctor near you: Color’s copilot and partnership with OpenAI

Color

What we do and whom we serve: A 10-year history of our work at Color